Feed Top Reports Pricing

⌘K

16:01:28·50d

SECFiling

SEC Form 20-F filed by Oculis Holding AG

OCS· Oculis Holding AG

Health Care

Full content unavailable. See the original source below.

Original source

Companies

OCS
Oculis Holding AG
Health Care

Recent analyst ratings

Dec 19UpdateAnalyst$38.00
Aug 27UpdateNeedham$36.00
Dec 5UpdateChardan Capital Markets$30.00
Oct 5UpdateStifel$35.00
Jun 14UpdateBofA Securities$22.00
Jun 12UpdateH.C. Wainwright$28.00

Related

SEC2d
SEC Form 6-K filed by Oculis Holding AG
PR2d
Oculis Publishes Invitation to the Annual General Meeting
PR4d
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
PR17d
Oculis to Participate in Upcoming Investor Conferences
PR24d
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis
SEC28d
Amendment: SEC Form SCHEDULE 13G/A filed by Oculis Holding AG
PR39d
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
PR50d
Oculis to Participate in Upcoming Investor Conferences

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022